Welltower (WELL) Gets a Buy Rating from Morgan Stanley

By Jason Carr

Morgan Stanley analyst Vikram Malhorta maintained a Buy rating on Welltower (WELLResearch Report) today and set a price target of $83. The company’s shares closed yesterday at $78.07, close to its 52-week high of $79.41.

According to TipRanks.com, Malhorta is a 3-star analyst with an average return of 2.9% and a 60.0% success rate. Malhorta covers the Financial sector, focusing on stocks such as Office Properties Income Trust, Boston Properties, and SL Green Realty.

Welltower has an analyst consensus of Moderate Buy, with a price target consensus of $78.17, representing a 0.1% upside. In a report released yesterday, Wells Fargo also maintained a Buy rating on the stock.

See today’s analyst top recommended stocks >>

Welltower’s market cap is currently $29.95B and has a P/E ratio of 85.31. The company has a Price to Book ratio of 2.15.

Based on the recent corporate insider activity of 44 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Welltower, Inc. engages in investing with seniors housing operators, post acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.